Ipatasertib
Who we are
The Rome Trial From Histology to Target: the Road to Personalize Target Therapy and Immunotherapy
A Trial of Ipatasertib in Combination With Atezolizumab
Tumor-Agnostic Precision Immuno-Oncology and Somatic Targeting Rational for You (TAPISTRY) Platform Study
Targeted Therapy Directed by Genetic Testing in Treating Patients With Advanced Refractory Solid Tumors, Lymphomas, or Multiple Myeloma (The MATCH Screening Trial)
